Investing Profile

Maximilian Winter(135)


Harmonizing Human Health

Photo of Maximilian Winter, General Partner at Harmonix Fund

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

6 Investors

Connected to Ian Rountree (Cantos Ventures), Wesley Chan (Felicis Ventures), Zal Bilimoria (Refactor Capital), and 3 other investors on Signal.

Harmonix Fund General Partner
$250K - $3.0M
CompanyStageDateRound SizeTotal Raised
Attivare Therapeutics
Series Seed 1 PreferredAug 2021$5M
Co-investors: Eric Anschutz
Series C - 2 PreferredJul 2021$100M
Co-investors: Alireza Masrour (Plug & Play Ventures)
Series BJun 2021$56.1M
Series AFeb 2015$8.5M
Co-investors: Armen Vidian (DCVC (Data Collective)), Josh Wolfe (Lux Capital), Matt Ocko (DCVC (Data Collective)), Adam Goulburn (Lux Capital), Brad Gillespie (IA Ventures), Paul Buchheit (Y Combinator)
Loft Orbital Solutions Inc.
Convertible Promissory NoteJun 2021$17M
Co-investors: Ashley Flucas (Flucas Ventures)
Series A-1 PreferredJun 2021$5.66M
Co-investors: william schneiderman
Scribe Biosciences
Convertible Promissory NoteMay 2021$4.5M
Series A PreferredMay 2021$13M
SeedSep 2020
Atlas Space
Convertible Promissory NoteApr 2021$5M
Post Series A BridgeApr 2020
Investing at the intersection of life sciences, healthcare, and deep tech. Many investments are platforms and tend to be computational bio-platforms.
Sectors outside of health, bio, and deep tech.
General Partner Harmonix Fund2020 - Present
Founder & CEO Neue Fund2017 - Present
University of Arizona Bachelor of Science Business/Finance